TOLNAFTATE POWDER, U

The contract specifies the procurement of TOLNAFTATE POWDER, USP 1%, in 45-gram units, identified by NSN 6505-01-480-7897 and NDC 57896-0199-45, with a total quantity of seven units—one unit under CLIN 0001 and six units under CLIN 0002—all requiring delivery within 20 days FOB destination with zero variance allowed. The item is classified as a Type I (Code Q) medical supply with a strictly non-extendable 36-month shelf life. All packaging must adhere to Medical Marking Standard No. 1, superseding MIL-STD-129, and must meet DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951 or Fed-Std-313. The product must be commercially packaged in sealed unit containers that protect against damage, with exterior shipping containers suitable for safe and economical transport via common carrier to the designated FPO address. Palletization must follow RP001 packaging requirements, and the unit of issue is defined as BT, equal to 45 grams. Hazardous material protocols apply only if warranted by Fed-Std-313; otherwise, commercial packaging standards govern. Shipping must avoid parcel post and utilize the fastest traceable means, with specific FOB and DLA vendor shipping instructions provided. The contract is issued under solicitation SPE2DP-26-T-4391, with a required delivery date of August 3, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Imerah Burnett designated as the primary point of contact.